Evidence map›Paper›PMID 33172004›Full record

ArticleMicroorganisms2020

Bile Acid Signal Molecules Associate Temporally with Respiratory Inflammation and Microbiome Signatures in Clinically Stable Cystic Fibrosis Patients.

Stephanie Flynn, F Jerry Reen, Jose A Caparrós-Martín, David F Woods, Jörg Peplies, Sarath C Ranganathan, Stephen M Stick, Fergal O'Gara

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Observational
  8. Review
  9. Review
  10. Bile effects on theHeliyon · 2023
    Review
  11. Efflux, Signaling and Warfare in a Polymicrobial World.Antibiotics (Basel, Switzerland) · 2023
    Review
  12. Article
  13. The Gut-Lung Axis in Cystic Fibrosis.Journal of bacteriology · 2021
    Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Stephanie FlynnBIOMERIT Research Centre, School of Microbiology, University College Cork, T12 K8AF Cork, Ireland.
F Jerry ReenBIOMERIT Research Centre, School of Microbiology, University College Cork, T12 K8AF Cork, Ireland.
Jose A Caparrós-MartínWal-yan Respiratory Research Centre. Telethon Kids Institute, 6009 Perth, Western Australia, Australia.ORCID 0000-0003-1214-4952
David F WoodsBIOMERIT Research Centre, School of Microbiology, University College Cork, T12 K8AF Cork, Ireland.ORCID 0000-0002-5623-6501
Jörg PepliesRibocon GmbH, Fahrenheitstraße. 1, 28359 Bremen, Germany.
Sarath C RanganathanDepartment of Respiratory Medicine, The Royal Children's Hospital, 3052 Melbourne, Australia.
Stephen M StickWal-yan Respiratory Research Centre. Telethon Kids Institute, 6009 Perth, Western Australia, Australia.
Fergal O'GaraBIOMERIT Research Centre, School of Microbiology, University College Cork, T12 K8AF Cork, Ireland.ORCID 0000-0002-2659-0673
The Kids Research Institute Australia · AUUniversity College Cork · IERibocon (Germany) · DERoyal Children's Hospital · AU

Funding

Cystic Fibrosis Foundation Grant CFF 1710European Comission EU-634486-INMAREHealth Research Board HRB-ILP-POR-2019-004Health Research Board MRCG-2014-6Health Research Board MRCG-2018-16NHMRC Synergy APP1183640Science Foundation Ireland SSP3-Pharm5: 15/TIDA/2977The Institute for Respiratory Health The Glenn Brown Memorial Grant 2017The Marine Institute Beaufort award C2CRA 2007/082
6 · The paper itself

Abstract

Cystic fibrosis (CF) is a congenital disorder resulting in a multisystemic impairment in ion homeostasis. The subsequent alteration of electrochemical gradients severely compromises the function of the airway epithelia. These functional changes are accompanied by recurrent cycles of inflammation-infection that progressively lead to pulmonary insufficiency. Recent developments have pointed to the existence of a gut-lung axis connection, which may modulate the progression of lung disease. Molecular signals governing the interplay between these two organs are therefore candidate molecules requiring further clinical evaluation as potential biomarkers. We demonstrate a temporal association between bile acid (BA) metabolites and inflammatory markers in bronchoalveolar lavage fluid (BALF) from clinically stable children with CF. By modelling the BALF-associated microbial communities, we demonstrate that profiles enriched in operational taxonomic units assigned to supraglottic taxa and opportunistic pathogens are closely associated with inflammatory biomarkers. Applying regression analyses, we also confirmed a linear link between BA concentration and pathogen abundance in BALF. Analysis of the time series data suggests that the continuous detection of BAs in BALF is linked to differential ecological succession trajectories of the lung microbiota. Our data provide further evidence supporting a role for BAs in the early pathogenesis and progression of CF lung disease.

Indexed as

bile acidscystic fibrosisgut–lung axisinflammationlung microbiota

Identifiers

PMID33172004
PMCPMC7694639
OpenAlexW3097282786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.